EUVIMEDEUVIMED entdecken
Crossref

MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma

Jiaqi Liang, Guoshu Bi, Yiwei Huang, Guangyin Zhao, Qihai Sui, Huan Zhang, Yunyi Bian, Jiacheng Yin, Qun Wang, Zhencong Chen, Cheng Zhan

Drug Resistance Updates · 2024-03 · 73 · 101057

DOI: 10.1016/j.drup.2024.101057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-03. Verfasst von Jiaqi Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China. Hauptthemen laut MEDLINE: Ferroptosis, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Lung cancer is the leading cause of cancer mortality and lung adenocarcinoma (LUAD) accounts for more than half of all lung cancer cases. Tumor elimination is mostly hindered by drug resistance and the mechanisms remain to be explored in LUAD. METHODS: CRISPR screens in cell and murine models and single-cell RNA sequencing were conducted, which identified MAF bZIP transcription factor F (MAFF) as a critical factor regulating tumor growth and treatment resistance in LUAD. RNA and ChIP sequencing analyses were performed for transcriptional target expression and specific binding sites of MAFF. Functions of MAFF in inhibiting tumor growth and promoting cisplatin or irradiation efficacy were investigated using cellular and xenograft models. RESULTS: Patients with lung adenocarcinoma and reduced MAFF expression had worse clinical outcomes. MAFF inhibited tumor cell proliferation by regulating the expression of SLC7A11, CDK6, and CDKN2C, promoting ferroptosis and preventing cell cycle progression from G1 to S. MAFF also conferred tumor cells vulnerable to cisplatin-based or ionizing radiation treatments. MAFF reduction was a final event in the acquisition of cisplatin resistance of LUAD cells. The intracellular cAMP/PKA/CREB1 pathway upregulated MAFF in response to cisplatin-based or ionizing radiation treatments. CONCLUSIONS: MAFF suppresses tumor growth, and pharmacological agonists targeting MAFF may improve cisplatin or irradiation therapies for lung adenocarcinoma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAdenocarcinoma of LungLung NeoplasmsHumansAnimalsMiceCisplatinCell Line, TumorCell ProliferationCell CycleNuclear ProteinsMafF Transcription Factor

Stichwörter der Autor:innen

Cisplatin-based therapyLung adenocarcinomaRadiotherapyTranscription factor

Substanzen

CisplatinMAFF protein, humanNuclear ProteinsMafF Transcription Factor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China. Electronic address: wang.qun@zs-hospital.sh.cn.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China. Electronic address: zcchen13@fudan.edu.cn.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China. Electronic address: czhan10@fudan.edu.cn.

Zitieren

APA

Liang, J., Bi, G., Huang, Y., Zhao, G., Sui, Q., Zhang, H., Bian, Y., Yin, J., Wang, Q., Chen, Z., & Zhan, C. (2024). MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resistance Updates, 73, 101057. https://doi.org/10.1016/j.drup.2024.101057

Vancouver

Liang J, Bi G, Huang Y, Zhao G, Sui Q, Zhang H, et al. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resistance Updates. 2024;73:101057. doi:10.1016/j.drup.2024.101057

BibTeX
@article{Liang2024,
  author = {Liang, Jiaqi and Bi, Guoshu and Huang, Yiwei and Zhao, Guangyin and Sui, Qihai and Zhang, Huan and Bian, Yunyi and Yin, Jiacheng and Wang, Qun and Chen, Zhencong and Zhan, Cheng},
  title = {MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {73},
  pages = {101057},
  doi = {10.1016/j.drup.2024.101057}
}
Kostenlos starten →